Dual roles of IL-15 in maintaining IL-7RαlowCCR7- memory CD8+ T cells in humans via recovering the phosphatidylinositol 3-Kinase/AKT pathway

被引:27
作者
Kim, Hang-Rae [1 ]
Hwang, Kyung-A [1 ]
Kang, Insoo [1 ]
机构
[1] Yale Univ, Rheumatol Sect TAC S541C, Dept Internal Med, New Haven, CT 06520 USA
关键词
D O I
10.4049/jimmunol.179.10.6734
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recently, we identified two subsets of CCR7(-) memory CD8(+) T cells expressing high and low levels of the IL-7R alpha-chain (IL-7R alpha) that is essential for memory T cell survival in human peripheral blood. IL-7R alpha(low)CCR7(-) memory CD8(+) T cells that produce effector cytokines and perforin have impaired proliferation and survival in response to TCR triggering and IL-7, respectively. These findings raise a question of how such cells are sustained at significant numbers, > 20% of peripheral CD8(+) T cells, despite impaired IL-7- and TCR-mediated cell maintenance. In this study, we demonstrate that IL-7R alpha(low)CCR7(-) memory CD8(+) T cells have increased expression of IL-2/15R beta-chain (IL-2/15R beta 3), which is critical for IL-15 signaling, with enhanced gene expression of T box expressed in T cells (T-bet) and eomesodermin (eomes), transcriptional factors involved in IL-2/15R beta expression compared with IL-7R alpha(high)CCR7(-) memory CD8(+) T cells. Such a cytokine chain is functional as IL-7R alpha(low)CCR7(-) memory CD8(+) T cells proliferate considerably in response to IL-15. Furthermore, adding IL-15 to TCR'triggering recovers impaired TCR-mediated proliferation of IL-7R alpha(low) memory CD8(+) T cells via restoring the activation of the PI3K/AKT pathway. These findings indicate that IL-15 has dual roles in maintaining IL-7R alpha(low)CCR7(-) memory CD8(+) T cells via TCR-dependent and -independent mechanisms. Moreover, IL-15 can be useful in reviving impaired proliferative function of such memory CD8(+) T cells with effector functions against infections and tumors via rescuing the PI3K/AKT pathway.
引用
收藏
页码:6734 / 6740
页数:7
相关论文
共 37 条
[21]   Cytoskeletal polarization of T cells is regulated by an immunoreceptor tyrosine-based activation motif-dependent mechanism [J].
Lowin-Kropf, B ;
Shapiro, VS ;
Weiss, A .
JOURNAL OF CELL BIOLOGY, 1998, 140 (04) :861-871
[22]   Control of T cell viability [J].
Marrack, P ;
Kappler, J .
ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :765-787
[23]   Interleukin-15: a new cytokine target for the treatment of inflammatory diseases [J].
McInnes, IB ;
Gracie, JA .
CURRENT OPINION IN PHARMACOLOGY, 2004, 4 (04) :392-397
[24]   Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool [J].
Melchionda, F ;
Fry, TJ ;
Milliron, MJ ;
McKirdy, MA ;
Tagaya, Y ;
Mackall, CL .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (05) :1177-1187
[25]   Human T cells constitutively express IL-15 that promotes ex vivo T cell homeostatic proliferation through autocrine/juxtacrine loops [J].
Miranda-Carús, ME ;
Benito-Miguel, M ;
Llamas, MA ;
Balsa, A ;
Martín-Mola, E .
JOURNAL OF IMMUNOLOGY, 2005, 175 (06) :3656-3662
[26]   Suppression of IL7Rα transcription by IL-7 and other prosurvival cytokines:: A novel mechanism for maximizing IL-7-dependent T cell survival [J].
Park, JH ;
Yu, Q ;
Erman, B ;
Appelbaum, JS ;
Montoya-Durango, D ;
Grimes, JL ;
Singer, A .
IMMUNITY, 2004, 21 (02) :289-302
[27]   Elevated serum interleukin-15 levels in systemic lupus erythematosus [J].
Park, YB ;
Kim, DS ;
Lee, WK ;
Suh, CH ;
Lee, SK .
YONSEI MEDICAL JOURNAL, 1999, 40 (04) :343-348
[28]   Failed adoptive immunotherapy with tumor-specifle T cells: Reversal with low-dose interleukin 15 but not low-dose interleukin 2 [J].
Roychowdhury, S ;
May, KF ;
Tzou, KS ;
Lin, T ;
Bhatt, D ;
Freud, AG ;
Guimond, M ;
Ferketich, AK ;
Liu, Y ;
Caligiuri, MA .
CANCER RESEARCH, 2004, 64 (21) :8062-8067
[29]   Cytokine control of memory T-cell development and survival [J].
Schluns, KS ;
Lefrançois, L .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (04) :269-279
[30]   Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo [J].
Schluns, KS ;
Kieper, WC ;
Jameson, SC ;
Lefrançois, L .
NATURE IMMUNOLOGY, 2000, 1 (05) :426-432